Schonfeld Strategic Advisors LLC Fate Therapeutics Inc Transaction History

Schonfeld Strategic Advisors LLC

$15.2 Billion
Q3 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 544,587 shares of FATE stock, worth $522,803. This represents 0.0% of its overall portfolio holdings.

Number of Shares

544,587

Previous 930,809 41.49%

Holding current value

$522,803

Previous $1.04 Million 34.17%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.92 - $1.3 $355,324 - $502,088	-386,222 Reduced 41.49%	544,587 $686,000
Q2 2025 Aug 14, 2025	SELL	$0.68 - $1.67 $4.67 Million - $11.5 Million	-6,863,704 Reduced 88.06%	930,809 $1.04 Million
Q1 2025 May 15, 2025	BUY	$0.79 - $1.87 $6.16 Million - $14.6 Million	7,794,513 New	7,794,513 $6.16 Million
Q1 2024 May 15, 2024	BUY	$3.54 - $8.35 $1.38 Million - $3.25 Million	389,468 Added 78.29%	886,925 $6.51 Million
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $789,124 - $1.88 Million	478,257 Added 2490.92%	497,457 $1.86 Million

Q3 2023 Nov 14, 2023	BUY	$2.02 - $5.04 $38,784 - $96,768	19,200 New	19,200 $40,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $533,859 - $1.29 Million	54,144 Added 63.81%	139,000 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $331,085 - $567,440	-15,736 Reduced 15.64%	84,856 $1.9 Million
Q2 2022 Aug 15, 2022	BUY	$17.78 - $42.39 $1.79 Million - $4.26 Million	100,592 New	100,592 $2.49 Million
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $297,082 - $483,335	-4,117 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $190,297 - $504,346	-4,996 Reduced 54.82%	4,117 $375,000
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $277,126 - $369,076	9,113 New	9,113 $0
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $1.29 Million - $2 Million	-96,400 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.47 - $22.5 $1.32 Million - $1.91 Million	85,035 Added 748.22%	96,400 $1.5 Million
Q2 2019 Aug 14, 2019	BUY	$15.61 - $20.44 $177,407 - $232,300	11,365 New	11,365 $231,000
Q4 2018 Feb 14, 2019	SELL	$11.48 - $16.98 $1.33 Million - $1.97 Million	-116,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$8.75 - $16.29 $1.02 Million - $1.89 Million	116,100 New	116,100 $1.89 Million

Others Institutions Holding FATE

# of Institutions

155

Shares Held

81.5M

Call Options Held

46.4K

Put Options Held

17.5K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $93.1M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Fate Therapeutics Inc Transaction History